1 hour ago
1
georgeclerk
Avalo Therapeutics (NASDAQ:AVTX) traded higher in the premarket on Friday after Cantor Fitzgerald initiated its coverage with an Overweight recommendation in a thesis centered on the Maryland-based biotech’s lead asset, AVTX-009.
Analyst Prakhar Agrawal’s bullish view comes as Avalo (
© FBT Company 2025. All rights are reserved
English (US) ·